Biography
Krishna P. Reddy, MD, MS, is a practicing pulmonary and critical care physician at Massachusetts General Hospital and an Associate Professor of Medicine at Harvard Medical School in Boston, Massachusetts, USA. He studies tuberculosis, HIV, and tobacco, individually and in combination. He applies methods of simulation modeling, epidemiology, and cost-effectiveness analysis to study clinical and economic outcomes. The goal of Dr. Reddy's research is to provide evidence- and model-based approaches to clinical decision-making and public health policy.
Key Impacts
Potential long-acting TB treatment for people with HIV in South Africa: Cost-effectiveness benchmarks
A long-acting injectable tuberculosis treatment regimen could be cost-effective if it maintains high efficacy at reasonable cost, especially when disengagement from standard oral treatment is high.
Source: Conference 2024
Cost-effectiveness of community tuberculosis screening in South Africa
Xpert and dCXR are likely cost-effective community tuberculosis screening strategies in South Africa but may require substantial scale-up investments. Higher tuberculosis prevalence or technological advances or cost reductions for dCXR/CAD could make dCXR+Xpert a cost-effective alternative.
Source: Conference 2024